Showing results (71-80 of 208) with videos related to

Sort By:
Pageof 21
Anticancer Research|April 19, 2011
Phase I trial of fenretinide lym-x-sorb oral powder in adults with solid tumors and lymphomasShivaani Kummar, Martin E Gutierrez, Barry J Maurer, et al.
Pediatric Blood & Cancer|February 9, 2012
Evaluation of arsenic trioxide by the pediatric preclinical testing program with a focus on Ewing sarcomaMalcolm A Smith, Min H Kang, C Patrick Reynolds, et al.
Journal of Molecular Medicine (Berlin, Germany)|October 12, 2012
Fenretinide sensitizes multidrug-resistant human neuroblastoma cells to antibody-independent and ch14.18-mediated NK cell cytotoxicityAnastasia Shibina, Diana Seidel, Srinivas S Somanchi, et al.
British Journal of Pharmacology|March 12, 2011
Fenretinide metabolism in humans and mice: utilizing pharmacological modulation of its metabolic pathway to increase systemic exposureJason P Cooper, Kyunghwa Hwang, Hardeep Singh, et al.
Journal of Neuro-Oncology|November 29, 2011
Novel cell lines established from pediatric brain tumorsJingying Xu, Anat Erdreich-Epstein, Ignacio Gonzalez-Gomez, et al.
Pediatric Blood & Cancer|October 28, 2010
Evaluation of cytarabine against Ewing sarcoma xenografts by the pediatric preclinical testing programPeter J Houghton, Christopher L Morton, Min Kang, et al.
Cancer Research|May 17, 2012
Mitochondrial Bcl-2 family dynamics define therapy response and resistance in neuroblastomaKelly C Goldsmith, Michelle Gross, Susan Peirce, et al.
Cancer Chemotherapy and Pharmacology|May 18, 2023
Phase I trial of intravenous fenretinide (4-HPR) plus safingol in advanced malignanciesAlexis C Boulter, Barry J Maurer, Meredith Pogue, et al.
Cancer Chemotherapy and Pharmacology|March 26, 2014
DrugPath: a database for academic investigators to match oncology molecular targets with drugs in developmentEric D Shah, Brandon M A Fisch, Robert J Arceci, et al.
Pageof 21